Home > About

About us

Board of Directors

Dr Cherrell Hirst
Chair

Board of Directors

Dr Cherrell Hirst
AO FTSE MBBS BEdSt D.Univ (Hon)
Chair
Dr Hirst has had a distinguished clinical career in the detection and diagnosis of breast cancer and extensive and respected achievements as a director of multiple commercial, government and not-for-profit organisations including as Chancellor of QUT from 1994-2004. Dr Hirst is currently Chair of ImpediMed Ltd and a director of Medibank Private Ltd, Gold Coast Hospital and Health Service and RSLCare and in addition she chairs the Advisory Board of the Institute of Molecular Biosciences at UQ. She has previously been a director of Hatchtech, Peplin, Suncorp and Avan amongst others.
Dr David Brookes
Non-Executive Director

Board of Directors

Dr David Brookes
MBBS FACRRM FAICD
Non-Executive Director
Dr Brookes has extensive experience in the health and biotechnology industries and is currently a Non-Executive director of Anatara Ltd (ASX:ANR). He has previously been a director of several other ASX listed biotechnology companies, most recently as the Chairman of genomics solutions company, RHS Ltd, which was acquired by PerkinElmer Inc (NYSE:PKI $9B biotech company) in June 2018. In addition to his directorships in listed biotechnology companies, Dr Brookes is currently Non-Executive Chairman of a private health services company, the Better Medical Group, and maintains roles as a clinician and a biotechnology industry consultant. Dr Brookes is a Fellow of the Australian College of Rural and Remote Medicine and a Fellow of the Australian Institute of Company Directors.
Dr Christian Behrenbruch
Non-Executive Director

Board of Directors

Dr Christian Behrenbruch
B.Eng (Hons) MBA D.Phil (Oxon) JD GAICD
Non-Executive Director
Dr Christian Behrenbruch has over 15 years of healthcare executive leadership experience. He previously served in CEO (and executive director) appointments at Mirada Solutions, CTI Molecular Imaging (now Siemens), Fibron Technologies and ImaginAb, Inc. He is a former director of Momentum Biosciences LLC, Siemens Molecular Imaging Ltd, Radius Health Ltd (now Adaptix) and Cell Therapies P/L (a partnership with the Peter MacCallum Cancer Centre). Dr Behrenbruch is currently a member of the Monash Engineering Foundation Board and holds adjunct appointments at Monash University and RMIT University.
John Michailidis
Non-Executive Director

Board of Directors

John Michailidis
B.Sc EMBA (Harv) MAICD FAIM
Non-Executive Director
Mr. Michailidis is currently the Managing Director for TEVA Australia/NZ and brings almost 30 years of commercial pharmaceutical experience to Factor. His career has ranged from global franchise and regional executive leadership roles with F. Hoffman – La Roche (Roche) to CEO experience with growth-stage biopharmaceutical companies, such as AviPep and Orphan Australia (acquired by Sigma). Mr. Michailidis holds a BSc in Genetics from LaTrobe University, and executive business qualifications from Harvard Business School and INSEAD.